Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 10 Colorectal Neoplasms 5 Stomach Neoplasms 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Biliary Tract Neoplasms 3 Sarcoma, Ewing 2 Recurrence 2 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Wilms Tumor 1 Small Cell Lung Carcinoma 1 Small Bowel Adenocarcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Cancer Patients 1 Peritoneal Neoplasms 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nasopharyngeal Carcinoma 1 Metastatic Gastric Adenocarcinoma 1 Metastatic Adenocarcinoma of the Pancreas 1 Malignant Ascites 1 Hepatoblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

pembrolizumab 27 Oxaliplatin 24 Paclitaxel 22 Fluorouracil 21 Carboplatin 18 Leucovorin 16 Cisplatin 16 Capecitabine 16 Radiotherapy 15 Nivolumab 12 Drug Therapy 12 Radiation 10 Trastuzumab 9 Surgical Procedures, Operative 9 Immunotherapy 8 Magnetic Resonance Spectroscopy 7 Esophagectomy 7 Blood Specimen Collection 7 Taxes 6 durvalumab 5 Surveys and Questionnaires 5 Specimen Handling 5 Radiotherapy, Intensity-Modulated 5 Irinotecan 5 Immune Checkpoint Inhibitors 5 Docetaxel 5 Bevacizumab 5 tislelizumab 4 Ramucirumab 4 Fluorodeoxyglucose F18 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × irinotecan sucrosofate × 1 year × Clear all

NCT03764553 2026-04-07

LyRICX

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡